- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04974762
Truncal Blocks Versus Wound Infiltration for SICD
August 2, 2022 updated by: Ali Nima Shariat, Icahn School of Medicine at Mount Sinai
Comparing Truncal Blocks Versus Wound Infiltration for Subcutaneous Implantable Cardioverter Defibrillator Implantation
This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation.
Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital.
They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks.
Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation.
Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital.
They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks.
Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay.
The procedures involved for the study are the placement of the described truncal blocks or wound infiltration.
Data to be collected are patient demographics, history of present illness, past medical history, and pain management techniques required (i.e non-narcotics and narcotics use).
In addition, age, race, gender and BMI will also be collected.
Intraoperative analgesia requirements, postoperative analgesia requirements, duration of procedure and length of stay will also be collected.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10025
- Mount Sinai Morningside Hospital Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients over 18 years of age
- Patients undergoing S-ICD placement
Exclusion Criteria:
- Allergy to amide local anesthetics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Wound infiltration
Standard intervention - surgical infiltration with local anesthetics
|
Surgical wound infiltration by proceduralist
|
|
Experimental: Truncal blocks
Truncal block for anesthetics
|
Truncal blocks provided by anesthesiology team for device placement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative and postoperative opioid consumption
Time Frame: Up to Post-Op Day 10
|
Total intraoperative and postoperative opioid consumption of subjects
|
Up to Post-Op Day 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Non-opioid analgesic consumption
Time Frame: Up to Post-Op Day 10
|
Total intraoperative and postoperative non-opioid analgesic consumption of subjects
|
Up to Post-Op Day 10
|
|
Sedation (propofol) requirements intraoperatively
Time Frame: Day 1, Day of Surgery
|
Total propofol required by subjects intraoperatively
|
Day 1, Day of Surgery
|
|
Number of participants with ICU stay
Time Frame: Up to Post-Op Day 10
|
Need of intensive care unit (ICU) stay
|
Up to Post-Op Day 10
|
|
Duration of ICU stay
Time Frame: Up to Post-Op Day 10
|
Duration of intensive care unit (ICU) stay
|
Up to Post-Op Day 10
|
|
Visual Analog Pain score
Time Frame: Up to Post-Op Day 10
|
Visual Analog Pain Score (VAS) - total scale from 0-10, with higher score indicating more pain
|
Up to Post-Op Day 10
|
|
Total procedure time
Time Frame: Day 1 at Surgery
|
Total duration of procedure time measured in minutes
|
Day 1 at Surgery
|
|
Length of stay
Time Frame: Day 1 at Surgery
|
Length of time in the postanesthesia care unit measured in minutes
|
Day 1 at Surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ali Shariat, MD, Icahn School Of Medicine At Mount Sinai
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 23, 2019
Primary Completion (Actual)
February 18, 2022
Study Completion (Actual)
February 18, 2022
Study Registration Dates
First Submitted
July 8, 2021
First Submitted That Met QC Criteria
July 22, 2021
First Posted (Actual)
July 23, 2021
Study Record Updates
Last Update Posted (Actual)
August 4, 2022
Last Update Submitted That Met QC Criteria
August 2, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-18-00379
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.